News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Antoun Houranieh, PhD

Articles by Antoun Houranieh, PhD

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts

ByAmy J. Grizzle, PharmD,Maysaa H. Mahmood, MS,Yu Ko, MS,John E. Murphy, PharmD,Edward P. Armstrong, PharmD,Grant H. Skrepnek, PhD,William N. Jones, MS,Gregory P. Schepers, PharmD,W. Paul Nichol, MD,Antoun Houranieh, PhD,Donna C. Dare, PharmD,Christopher T. Hoey, PharmD,Daniel C. Malone, PhD

October 1st 2007

Latest Updated Articles

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts
Published: October 1st 2007 | Updated:

Trending on AJMC

Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps

Howard A. “Skip” Burris, III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose

Employer Premiums and Deductibles Consume Significant Portion of Income in 19 States

New Bill Makes CMS Enforcer in PBM, Pharmacy Relationship: A Q&A With Jesse Dresser, Esq

Debunking Myths to Boost Clinical Trial Enrollment Diversity: Susan Vadaparampil, PhD, MPH